Sarepta Therapeutics Inc (LTS:0L35) Transcripts
Q3 2024 Sarepta Therapeutics Inc Earnings Call Transcript
Nov 06, 2024
$126.42
(+2.09%)
Earnings
Q2 2024 Sarepta Therapeutics Inc Earnings Call Transcript
Aug 07, 2024
$140.9
(-1.51%)
Earnings
Q1 2024 Sarepta Therapeutics Inc Earnings Call Transcript
May 01, 2024
$128.37
(-0.22%)
Earnings
Q4 2023 Sarepta Therapeutics Inc Earnings Call Transcript
Feb 28, 2024
$137.1
(-1.96%)
Earnings
Sarepta Therapeutics Inc To Provide Program Update Transcript
Jan 29, 2024
Sarepta Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Jan 08, 2024
Sarepta Therapeutics Inc at UBS BioPharma Conference Transcript
Nov 09, 2023
Q3 2023 Sarepta Therapeutics Inc Earnings Call Transcript
Nov 01, 2023
$75.99
(+21.79%)
Earnings
Sarepta Therapeutics Inc Update Call Transcript
Oct 30, 2023
Sarepta Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 11, 2023
Q2 2023 Sarepta Therapeutics Inc Earnings Call Transcript
Aug 02, 2023
$105.57
(-2.66%)
Earnings
Sarepta Therapeutics Inc at TD Cowen RNA Therapeutics Summit (Virtual) Transcript
Jul 10, 2023
Sarepta Therapeutics Inc ELEVIDYS FDA Accelerated Approval Call Transcript
Jun 22, 2023
Q1 2023 Sarepta Therapeutics Inc Earnings Call Transcript
May 02, 2023
$125.15
(+0.88%)
Earnings
Sarepta Therapeutics Inc SRP-9001 BLA Update Call Transcript
Mar 16, 2023
Q4 2022 Sarepta Therapeutics Inc Earnings Call Transcript
Feb 28, 2023
$118.65
Earnings
Sarepta Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Jan 09, 2023
Sarepta Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript
Dec 01, 2022
Q3 2022 Sarepta Therapeutics Inc Earnings Call Transcript
Nov 02, 2022
$117.14
(+0.73%)
Earnings
Sarepta Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 12, 2022
Q2 2022 Sarepta Therapeutics Inc Earnings Call Transcript
Aug 02, 2022
$92.33
(-0.46%)
Earnings
Sarepta Therapeutics Inc to Discuss New Clinical Data and Integrated Analysis Call Transcript
Jul 06, 2022
Sarepta Therapeutics Inc to Provides Update on SRP-5051 for the Treatment of Duchenne Transcript
Jun 23, 2022
Sarepta Therapeutics Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 14, 2022
Sarepta Therapeutics Inc Annual Shareholders Meeting Transcript
Jun 02, 2022
Sarepta Therapeutics Inc at Bank of America Healthcare Conference Transcript
May 11, 2022
Q1 2022 Sarepta Therapeutics Inc Earnings Call Transcript
May 04, 2022
$75.88
Earnings
Sarepta Therapeutics Inc at Guggenheim Genomic Medicines and Rare Disease Day (Virtual) Transcript
Mar 31, 2022
Sarepta Therapeutics Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Mar 15, 2022
Sarepta Therapeutics Inc at Cowen Health Care Conference (Virtual) Transcript
Mar 09, 2022
Q4 2021 Sarepta Therapeutics Inc Earnings Call Transcript
Mar 01, 2022
$77.85
Earnings
Sarepta Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) and Q&A Session Transcript
Jan 10, 2022
Sarepta Therapeutics Inc at Evercore ISI HealthCONx Virtual Conference Transcript
Nov 30, 2021
Sarepta Therapeutics Inc at Barclays Gene Editing & Gene Therapy Summit (Virtual) Transcript
Nov 15, 2021
Sarepta Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 09, 2021
Q3 2021 Sarepta Therapeutics Inc Earnings Call Transcript
Nov 03, 2021
$80.71
Earnings
Sarepta Therapeutics Inc to host SRP-9001 Micro-dystrophin R&D Day Transcript
Oct 11, 2021
Sarepta Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Sep 27, 2021
Sarepta Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 13, 2021
Q2 2021 Sarepta Therapeutics Inc Earnings Call Transcript
Aug 04, 2021
$69.75
Earnings
Sarepta Therapeutics Inc at Bank of America NAPA Healthcare Conference Transcript
Jun 16, 2021
Sarepta Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 10, 2021
Sarepta Therapeutics Inc Annual Shareholders Meeting Transcript
Jun 03, 2021
Sarepta Therapeutics Inc at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript
May 18, 2021
Sarepta Therapeutics Inc Clinical Update: Study SRP-9001-103: 12-Week Expression and Safety Data Using Commercially Representative Material - Call Transcript
May 18, 2021
Sarepta Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 11, 2021
Q1 2021 Sarepta Therapeutics Inc Earnings Call Transcript
May 05, 2021
$74.94
Earnings
Sarepta Therapeutics Inc to Discuss Results from 30 mg/kg Cohort of MOMENTUM Study of SRP-5051 for Duchenne Muscular Dystrophy Call Transcript
May 03, 2021
Pfizer Inc, Avidity Biosciences, Sarepta Therapeutics, Solid Biosciences, and Ultragenyx Pharmaceutical at Guggenheim Partners Healthcare Talks: Genomic Medicines & Rare Disease (Virtual) Transcript
Apr 01, 2021
Sarepta Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Mar 10, 2021
Sarepta Therapeutics Inc at Cowen Healthcare Conference (Virtual) Transcript
Mar 03, 2021
Q4 2020 Sarepta Therapeutics Inc Earnings Call Transcript
Mar 01, 2021
$86.88
(-0.23%)
Earnings
Sarepta Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2021
Sarepta Therapeutics Inc Announces Top-line Results from Part 1 of Study SRP-9001-102 Conference Call Transcript
Jan 07, 2021
Sarepta Therapeutics Inc to Present Clinical Update for SRP-5051 Conference Call Transcript
Dec 07, 2020
Sarepta Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript
Dec 02, 2020
Sarepta Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 09, 2020
Q3 2020 Sarepta Therapeutics Inc Earnings Call Transcript
Nov 05, 2020
$139.77
Earnings
Sarepta Therapeutics Inc Conference Call to Discuss Long-term Functional Data from Gene Therapy Programs to be Presented at WMS25 Transcript
Sep 28, 2020
Sarepta Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Sep 16, 2020
Sarepta Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 15, 2020
Sarepta Therapeutics Inc at Robert W Baird Global Healthcare Conference Transcript
Sep 10, 2020
Q2 2020 Sarepta Therapeutics Inc Earnings Call Transcript
Aug 05, 2020
$172.87
Earnings
Sarepta Therapeutics Inc at Bank of America Merrill Lynch Napa Healthcare Conference (Virtual) Transcript
Jun 24, 2020
Sarepta Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 09, 2020
Sarepta Therapeutics Inc Clinical Update: SRP-9003 for Limb-Girdle Muscular Dystrophy Type 2E Conference Call Transcript
Jun 08, 2020
Sarepta Therapeutics Inc Annual Shareholders Meeting Transcript
Jun 04, 2020
Sarepta Therapeutics Inc at RBC Global Healthcare Conference (Virtual) Transcript
May 19, 2020
Q1 2020 Sarepta Therapeutics Inc Earnings Call Transcript
May 06, 2020
$118.29
Earnings
Q4 2019 Sarepta Therapeutics Inc Earnings Call Transcript
Feb 26, 2020
$123.86
Earnings
Sarepta Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Jan 13, 2020
Sarepta Therapeutics Inc to Discuss Partnership with Roche Holding AG for its Investigational Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy Call Transcript
Dec 23, 2019
Sarepta Therapeutics Inc at Credit Suisse Healthcare Conference - Scottsdale Transcript
Nov 12, 2019
Q3 2019 Sarepta Therapeutics Inc Earnings Call Transcript
Nov 07, 2019
$93.68
(+8.08%)
Earnings
Sarepta Therapeutics Inc Limb-Girdle Muscular Dystrophy Type 2E Conference Call Transcript
Oct 04, 2019
Sarepta Therapeutics Inc at Morgan Stanley Healthcare Conference Transcript
Sep 09, 2019
Q2 2019 Sarepta Therapeutics Inc Earnings Call Transcript
Aug 07, 2019
$143.01
Earnings
Sarepta Therapeutics Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 11, 2019
Q1 2019 Sarepta Therapeutics Inc Earnings Call Transcript
May 08, 2019
$112.95
Earnings
Sarepta Therapeutics Inc Update on Duchenne Muscular Dystrophy Gene Therapy Program Conference Call Transcript
Mar 25, 2019
Q4 2018 Sarepta Therapeutics Inc Earnings Call Transcript
Feb 27, 2019
$148.77
(+2.76%)
Earnings
Sarepta Therapeutics Inc to Announce Results of Phase I/IIa Gene Transfer Clinical Trial using MYO-101 - Conference Call Transcript
Feb 27, 2019